SCHEMBL2015184

SCHEMBL2015184

CCN1CC(C)(C)OC(=O)C1CC(=O)NC(C)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
KDM4E B2RXH2 1/20 0.45
ALOX15 P16050 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HSD17B10 Q99714 1/20 0.45
KMT2A Q03164 3/20 0.44
POLB P06746 1/20 0.44
BDKRB1 P46663 1/20 0.43
MAPK1 P28482 1/20 0.43
IDO1 P14902 1/20 0.43
MEN1 O00255 2/20 0.43
PKM P14618 2/20 0.43
NPC1 O15118 1/20 0.43
ALOX12 P18054 1/20 0.41
MAPT P10636 2/20 0.40
GPR139 Q6DWJ6 1/20 0.40
ACHE P22303 2/20 0.40
TSHR P16473 1/20 0.40
MDM2 Q00987 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2013353 0.81 CACNA1G (0.45) ALDH1A1KDM4EHSD17B10KMT2APOLB
SCHEMBL2011927 0.77 ALDH1A1 (0.50) ALDH1A1KDM4EKMT2APOLBMEN1
SCHEMBL2013234 0.76 ALDH1A1 (0.47) ALDH1A1KDM4ESMN1; SMN2KMT2APOLB
SCHEMBL2013918 0.75 MAPT (0.40) ALDH1A1SMN1; SMN2KMT2APOLBMAPT
SCHEMBL16168628 0.74 MAPT (0.36) ALDH1A1KDM4EKMT2APOLBMAPT
SCHEMBL2011699 0.73 LMNA (0.46) ALDH1A1KDM4EKMT2AMAPK1MEN1
SCHEMBL2017246 0.73 MAPT (0.43) SMN1; SMN2KMT2APOLBMAPT
SCHEMBL2013720 0.73 MAPT (0.56) ALDH1A1KDM4EKMT2AMEN1MAPT
SCHEMBL2016452 0.72 MAPT (0.46) ALDH1A1KDM4EKMT2APOLBNPC1
SCHEMBL2014175 0.71 MAPT (0.35) ALDH1A1SMN1; SMN2KMT2APOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2513069-B1 ANTIFUNGAL COMPOUNDS UNIV LEUVEN KATH (BE) 2014-10-15 EP claimed
EP-2513069-A1 ANTIFUNGAL COMPOUNDS Katholieke Universiteit Leuven (BE) 2012-10-24 EP claimed
US-20120252801-A1 ANTIFUNGAL COMPOUNDS KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D (BE) 2012-10-04 US claimed
WO-2011072345-A1 ANTIFUNGAL COMPOUNDS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2011-06-23 WO claimed
EP-2513069-B1 ANTIFUNGAL COMPOUNDS UNIV LEUVEN KATH (BE) 2014-10-15 EP disclosed
EP-2513069-A1 ANTIFUNGAL COMPOUNDS Katholieke Universiteit Leuven (BE) 2012-10-24 EP disclosed
US-20120252801-A1 ANTIFUNGAL COMPOUNDS KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D (BE) 2012-10-04 US disclosed
US-20120252801-A1 ANTIFUNGAL COMPOUNDS KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D (BE) 2012-10-04 US disclosed
WO-2011072345-A1 ANTIFUNGAL COMPOUNDS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2011-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120252801-A1 ANTIFUNGAL COMPOUNDS ERG28, DPM1, CYP51A1 ALDH1A1 2899/4885KDM4E 3907/4885ALOX15 2352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.